• About us
    • About Lindahl
    • How we work
    • Said about Lindahl
    • Press
    • Find us
    • Privacy
  • Areas
    • Commercial dispute resolution
    • IT/Tech
    • Intellectual property
    • Life Sciences
    • M&A
    • All areas
  • Our people
    • Stockholm
    • Göteborg
    • Malmö
    • Uppsala
    • Helsingborg
    • Örebro
  • Latest news
    • Cases and transactions
    • News
    • Events
    • Knowledge
    • Portraits
  • Offices
    • Stockholm
    • Göteborg
    • Malmö
    • Uppsala
    • Örebro
    • Helsingborg

Lindahl advises in the listing of Intervacc

  • Home
  • Latest news
  • Cases and transactions
  • 2017
  • Lindahl advises in the listing of Intervacc

Advokatfirman Lindahl has advised Intervacc AB on its listing on Nasdag First North and the issue of units directed to the public in Sweden and to institutional investors, which is carried out as a part of the listing. A prospectus in respect of the listing and the new issue has been made public on 23 February 2017, and the preliminary date for first day of trading on Nadsaq First North is 7 April 2017.

Intervacc AB is a company in the biotechnology sector. The company's main area is to develop modern subunit vaccines for economically important bacterial infections, primarily in animal health care. The company's vaccine candidates are based on many years of research at the Karolinska Institute and the Swedish University of Agricultural Sciences that laid the foundation for the technology platform that forms the basis for the Company's research and development.

Advokatfirman Lindahl assisted Intervacc in the listing and the new issue through a team lead by Per Hedman (Life sciences) and Annika Andersson (Capital Markets and Public M&A), together with Olivia Toftgård, Anton Knifström and Oscar Lunde (Capital Markets and Public M&A), Erik Sundgren and Natalie Tell (M&A), Annie Kabala (Intellectual Property) and Anna Romell Stenmark and Therese Norenäs (Tax).

Contact

  • Anna Romell Stenmark

    Uppsala

    anna.romell.stenmark@lindahl.se +46 705 261 863
Pages
  • Start
  • About us
  • Areas
  • Our people
  • Latest news
  • Privacy
Our offices
  • Stockholm reception.stockholm@lindahl.se +46 8 527 70 800
  • Göteborg reception.goteborg@lindahl.se +46 31 799 10 00
  • Malmö reception.malmo@lindahl.se +46 40 664 66 50
  • Uppsala reception.uppsala@lindahl.se +46 18 16 18 50
  • Örebro reception.orebro@lindahl.se +46 19 20 89 00
  • Helsingborg reception.helsingborg@lindahl.se +46 42 17 53 00
Social media
  • Connect with us on social networks: Instagram, Linkedin, Youtube, Facebook,

Disclaimer

The material and information on this site is intended for general informational purposes only and does not constitute legal advice on any specific matter. Please note that all images on Lindahl's website, www.lindahl.se, are subject to intellectual property protection and downloading, publication, copying and/or other use of the images requires the written consent of the rights holder. You'll find Advokatfirman Lindahl KB's general terms and conditions here.

Some cookies are essential, others help us improve your experience by providing insights into how the site is used. For more information, please visit our Cookie Policy.

Essential Cookies

These cookies are necessary for the functionality of the site and cannot be disabled.

Analytics Cookies>

We use Analytics cookies to collect information that gives us insight into how our website is being used. We anonymize IP addresses in Google Analytics. By clicking on Decline we won't save theese cookies.

Decline
We use cookies to get insights on how our site is used and give our visitors the best possible experience